芬兰的阻塞性呼吸道疾病药物使用者的诊断和处方模式
Pekka Juntunen1,2, Petri Salmela3,4, Johanna Pakkasela3,4
1Department of Respiratory Medicine, Tampere University Hospital, PO Box 2000, Tampere, N33521, Finland. pjuntunen@fimnet.fi.
BMC pulmonary medicine
|January 31, 2024
概括
对阻塞性呼吸道疾病 (R03) 的药物使用在芬兰很常见. 吸入性皮质类固醇 (ICS) 经常用于喘,但也经常用于COPD,甚至用于没有这些疾病的患者.
科学领域:
- 肺部医学 肺部医学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 喘和COPD是普遍存在的呼吸道疾病,在初级保健中得到管理.
- 关于R03药物 (阻塞性呼吸道疾病) 的使用模式的国家级数据以前没有.
研究的目的:
- 为了确定R03药物的不同类别的诊断指示.
- 分析各种R03药物类在喘和COPD管理中的使用模式.
- 评估在芬兰未被诊断为喘或慢性肺炎患者中使用R03药物的频率.
主要方法:
- 调查问卷被发送给2000名随机选择的芬兰人,他们在前一年接受了R03药物.
- 通过问卷收集了医生诊断的喘和COPD状态.
- 发行R03药物的数据来自国家注册表.
主要成果:
- 在803名受访者中 (40.6%的应答率),61.6%患有喘,5.1%患有慢性肺炎,5.7%患有两种疾病,而27.5%没有这两种疾病.
- 吸入性皮质类固醇 (ICS) 是最常见的R03类药物用于喘 (93.7%) 和喘/COPD (97.8%).
- ICS也经常用于COPD (68.3%),类似于长效支气管扩展剂 (70.7%),并在27.5%的没有喘或COPD的患者中使用.
结论:
- 与COPD相比,R03药物主要用于喘.
- 虽然喘治疗符合有利于ICS的指导方针,但在COPD管理中似乎过度利用ICS.
- 很大一部分R03药物被分配给缺乏正式喘或COPD诊断的患者.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Physical Assessment of the Respiratory Tract I: Health History
221
Physical assessment of the respiratory tract is critical to patient care. It allows healthcare professionals to identify and manage various respiratory conditions. The process involves a combination of subjective and objective data collection.
Subjective Data
Subjective data provides vital information about the patient's health history and symptoms. This data is typically collected through interviews in which patients describe their experiences, symptoms, and concerns.
Health history and...
Subjective Data
Subjective data provides vital information about the patient's health history and symptoms. This data is typically collected through interviews in which patients describe their experiences, symptoms, and concerns.
Health history and...
221
COPD: Management Using Bronchodilators and Corticosteroids
207
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
207
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


